A friend asked Huazi how to treat chronic atrophic gastritis, whether it can be cured, and how long should the medicine be taken? Huazi replied that chronic atrophic gastritis (CAG) is a difficult disease. The World Health Organization (WHO) classifies it as a precancerous condition. It develops slowly and the condition often lingers. Chronic atrophic gastritis is a chronic gastric disease that causes repeated damage to the gastric mucosal epithelium, leading to a decrease in intrinsic glands, and may be accompanied by intestinal metaplasia or atypical hyperplasia. At present, there is a lack of effective treatment for chronic atrophic gastritis. The treatment mainly relies on individualized medication based on symptoms to relieve symptoms and delay the progression of lesions, thereby reducing the risk of cancer. 1. Eliminate Helicobacter pylori (Hp) Helicobacter pylori infection is the most common cause of chronic atrophic gastritis. After being infected with Helicobacter pylori, it will cause long-term inflammatory stimulation to the gastric mucosa, induce an immune response, and cause gastric mucosal atrophy and intestinal metaplasia in some patients. People with chronic atrophic gastritis need to be promptly cleared of Helicobacter pylori infection if they are also infected. The Fifth National Consensus Report on the Treatment of Helicobacter pylori Infection states that eradication of Helicobacter pylori can eliminate inflammatory responses, slow down or stop the progression of atrophy, and may even reverse atrophy. The current method for eliminating Helicobacter pylori in my country is mainly "quadruple therapy", which is to use a proton pump inhibitor, a bismuth preparation, and two antibiotics to form a combination of four drugs, which are taken continuously for 14 days. The elimination rate of "quadruple therapy" is about 60%~70%. If the elimination fails, other antibiotics should be replaced at least 3 months later and treatment should be repeated. There is also research on "dual therapy" to eliminate Helicobacter pylori. The treatment idea is to choose one proton pump inhibitor and one antibiotic to form a two-drug combination regimen, also taken for 14 days. By increasing the drug dosage and administration frequency to increase the drug effect, the same therapeutic effect as "quadruple therapy" can be achieved, but with fewer adverse reactions and lower costs. The specific method and medication should be selected under the guidance of a doctor. 2. Symptomatic treatment for different symptoms Patients with chronic atrophic gastritis have different clinical symptoms and need individualized medication and symptomatic treatment based on different symptoms. 1. If there is gastric mucosal erosion, upper abdominal pain, upper abdominal burning sensation and other symptoms: gastric mucosal protectants are needed, such as aluminum carbonate magnesium, sucralfate and other drugs that can cover the mucosa to produce a protective effect, and can also absorb bile to treat gastric mucosal damage caused by bile reflux. Antacids are needed to reduce the damage of gastric acid to the gastric mucosa. Drugs that directly neutralize gastric acid, such as sodium bicarbonate and aluminum hydroxide, take effect quickly but last for a short time. Therefore, proton pump inhibitors ("prazole" drugs) are often used to keep the pH value in the stomach > 4 for 18 hours. H2 receptor inhibitors ("tidin" drugs) can also be used to keep the pH value in the stomach > 4 for 8 hours. 2. Symptoms of indigestion such as upper abdominal fullness, nausea, vomiting, etc.: Gastrokinetic drugs are needed, and commonly used drugs include domperidone, mosapride, itopride, etc. However, domperidone has a rare adverse reaction that can cause serious arrhythmias, so the latter two gastrokinetic drugs are more commonly used. 3. Symptoms of decreased digestive function such as abdominal distension and decreased appetite when eating: Digestive enzyme preparations are needed, such as pancreatic enzyme enteric-coated capsules, Aspergillus oryzae pancreatic enzymes, compound digestive enzymes, compound azintamide and other drugs, which can enhance the activity of digestive enzymes and promote digestive function. 4. Digestive tract symptoms accompanied by anxiety and depression symptoms: Long-term anxiety and depression can cause digestive tract symptoms, and long-term physical discomfort can induce anxiety and depression. Therefore, when symptomatic treatment drugs are ineffective, you can try to seek treatment from a psychologist. Using anti-anxiety drugs and antidepressant drugs under the guidance of a doctor may have unexpected effects. In summary, the treatment of chronic atrophic gastritis is mainly to relieve symptoms and reduce the risk of cancer. Helicobacter pylori infection must be cleared in time. Symptomatic treatment is carried out according to different symptoms, and the effect is usually seen in about 4 weeks. Drugs that inhibit gastric acid secretion are not recommended for long-term use, and can be discontinued after symptoms are relieved. Drugs must be used under the guidance of a doctor. If you have any questions about the use of drugs, please consult a doctor or pharmacist. I am pharmacist Huazi, welcome to follow me and share more health knowledge. |
>>: Woke up with a bald head? Don't worry! You just need to...
What is Monkeypox Monkeypox is a zoonosis caused ...
Many female friends will encounter some special s...
Leviathan Press: Whether differential treatment i...
Menstruation, also known as menstruation, is an o...
Generally, there will be no bleeding 24 days afte...
After 40 weeks of pregnancy, the delivery period ...
The ovaries are very important reproductive organ...
Pregnant women need to have regular prenatal chec...
There are situations where women cannot have chil...
Breast---High incidence Of all the organs, the br...
The tightness of a woman's vagina determines ...
Many people in their lives are always unable to f...
Many women have abortions for various reasons, bu...
Many pregnant women will experience corresponding...
HPV is human papillomavirus infection. HPV58 posi...